Market Cap 50.90B
Revenue (ttm) 21.84B
Net Income (ttm) 1.68B
EPS (ttm) N/A
PE Ratio 14.21
Forward PE 14.58
Profit Margin 7.68%
Debt to Equity Ratio 0.55
Volume 884,782
Avg Vol 1,992,046
Day's Range N/A - N/A
Shares Out 275.54M
Stochastic %K 9%
Beta 0.21
Analysts Sell
Price Target $190.47

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 847 6800
Website: www.bd.com
Address:
1 Becton Drive, Franklin Lakes, United States
spql8r
spql8r Aug. 25 at 6:27 PM
$AMFN During my working years with $LH and $DGX, we deal with companies like $BDX and $DHR, which have a ton of patents. I remember LabCorp one day when it was looking to buy a lab in Tustin, CA. When I researched the lab, it did not have much volume. What's interesting is it has a lot of patents. The big 2 labs usually buy the lab because they have the volume, because volume equals revenue. So patents are important. AMFN is preparing for the future with revenues from the patents or exclusivity. In the lab business, they usually pay 5x the revenue. I know, it's less than the multiplier in other fields since it's 10 to 30 times more. What we have here—commercialization of Texatron, a fusion engine soon to power up data centers—is unique. Rarity also has a multiplier. Take a look, NFA. DYODD.😎 5737👀
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 2:07 AM
$BDX Price: $192.00 (+2.33%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.59% RSI: 85.3 | Momentum: Moderate Volume: -7.2% vs avg Volatility: 1.72% Support: $157.09 | Resistance: $192.29 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 21 at 5:31 PM
$BDX printed a new 52-week high today
0 · Reply
ZacharyBrooks497
ZacharyBrooks497 Aug. 20 at 7:35 AM
$LHX $CBRS $DEO $BDX $STT L3Harris benefits from defense and aerospace spending, CBRS remains speculative, Diageo benefits from global beverage demand, Becton Dickinson benefits from medical-device and healthcare demand, and State Street benefits from asset servicing and investment activity. I'm watching defense contracts, liquidity, consumer volumes, procedure demand, and asset flows.
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 19 at 7:01 PM
$BDX printed a new 52-week high today
0 · Reply
heikoscreens
heikoscreens Aug. 18 at 5:55 PM
These are the current Dividend Aristocrats: $BDX $DOV $EMR $GWW $JNJ ...
1 · Reply
TalkMarkets
TalkMarkets Aug. 14 at 2:53 AM
Buy, Sell, Or Hold These 4 Dividend Kings After Earnings: BDX, ED, EMR, PH $BDX $ED $EMR $PH https://talkmarkets.com/article/buy-sell-or-hold-these-4-dividend-kings-after-earnings-bdx-ed-emr-ph-1786675988
0 · Reply
TalkMarkets
TalkMarkets Aug. 11 at 6:43 AM
BDX: A Dividend King In The Medical Supply Business $BDX Also Mentions: $WAT https://talkmarkets.com/article/bdx-a-dividend-king-in-the-medical-supply-business-1786430481
0 · Reply
AlphaTradingRoom
AlphaTradingRoom Aug. 6 at 4:41 PM
$BDX beat and raised. Medical devices are holding up better than people feared in this macro. But hospital budgets are the first thing CFOs cut when recession fears spike. Too early to call this a safe haven.
1 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 1:02 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-becton-dickinson-and-company-stock/ $BDX Becton, Dickinson and Company Earnings Trans
0 · Reply
Latest News on BDX
3 Dividend Stocks From a Value Pro

Sep 4, 2026, 3:00 AM EDT - 4 days ago

3 Dividend Stocks From a Value Pro

BDX NE


Becton, Dickinson and Company Slides: Q3 2026

Aug 6, 2026, 8:00 AM EDT - 4 weeks ago

Becton, Dickinson and Company Slides: Q3 2026


Becton, Dickinson and Company Earnings release: Q3 2026

Aug 6, 2026, 8:00 AM EDT - 4 weeks ago

Becton, Dickinson and Company Earnings release: Q3 2026


Becton, Dickinson and Company Quarterly report: Q3 2026

Aug 6, 2026, 8:00 AM EDT - 4 weeks ago

Becton, Dickinson and Company Quarterly report: Q3 2026


BD Reports Third Quarter Fiscal 2026 Financial Results

Aug 6, 2026, 6:30 AM EDT - 4 weeks ago

BD Reports Third Quarter Fiscal 2026 Financial Results

BDX


BD Board Declares Dividend

Jul 28, 2026, 4:15 PM EDT - 5 weeks ago

BD Board Declares Dividend

BDX


Mike Garrison to Retire from BD

Jul 22, 2026, 6:55 AM EDT - 6 weeks ago

Mike Garrison to Retire from BD

BDX


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 2 months ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


Peter Menziuso Named EVP and President, BD Interventional

May 18, 2026, 6:50 AM EDT - 3 months ago

Peter Menziuso Named EVP and President, BD Interventional

BDX


AI, Robotics Key to Transforming Health Care: BD CEO

May 15, 2026, 10:36 AM EDT - 3 months ago

AI, Robotics Key to Transforming Health Care: BD CEO

BDX


Becton, Dickinson and Company Earnings Call Transcript: Q2 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Becton, Dickinson and Company Earnings Call Transcript: Q2 2026


Becton, Dickinson and Company Slides: Q2 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Becton, Dickinson and Company Slides: Q2 2026


Becton, Dickinson and Company Earnings release: Q2 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Becton, Dickinson and Company Earnings release: Q2 2026


Becton, Dickinson and Company Quarterly report: Q2 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Becton, Dickinson and Company Quarterly report: Q2 2026


BD Appoints Vitor Roque Chief Financial Officer

May 7, 2026, 6:31 AM EDT - 4 months ago

BD Appoints Vitor Roque Chief Financial Officer

BDX


BD Reports Second Quarter Fiscal 2026 Financial Results

May 7, 2026, 6:30 AM EDT - 4 months ago

BD Reports Second Quarter Fiscal 2026 Financial Results

BDX


Rick Byrd to Retire from BD

Apr 9, 2026, 4:05 PM EDT - 5 months ago

Rick Byrd to Retire from BD

BDX


Lanesha Minnix Named General Counsel for BD

Feb 19, 2026, 4:15 PM EST - 6 months ago

Lanesha Minnix Named General Counsel for BD

BDX


Becton, Dickinson and Company Earnings Call Transcript: Q1 2026

Feb 9, 2026, 8:00 AM EST - 7 months ago

Becton, Dickinson and Company Earnings Call Transcript: Q1 2026


Becton, Dickinson and Company Quarterly report: Q1 2026

Feb 9, 2026, 8:00 AM EST - 7 months ago

Becton, Dickinson and Company Quarterly report: Q1 2026


Becton, Dickinson and Company Earnings release: Q1 2026

Feb 9, 2026, 8:00 AM EST - 7 months ago

Becton, Dickinson and Company Earnings release: Q1 2026


Becton, Dickinson and Company Slides: Q1 2026

Feb 9, 2026, 8:00 AM EST - 7 months ago

Becton, Dickinson and Company Slides: Q1 2026


BD Reports First Quarter Fiscal 2026 Financial Results

Feb 9, 2026, 6:30 AM EST - 7 months ago

BD Reports First Quarter Fiscal 2026 Financial Results

BDX


Becton, Dickinson and Company Transcript: AGM 2026

Jan 27, 2026, 1:00 PM EST - 7 months ago

Becton, Dickinson and Company Transcript: AGM 2026


spql8r
spql8r Aug. 25 at 6:27 PM
$AMFN During my working years with $LH and $DGX, we deal with companies like $BDX and $DHR, which have a ton of patents. I remember LabCorp one day when it was looking to buy a lab in Tustin, CA. When I researched the lab, it did not have much volume. What's interesting is it has a lot of patents. The big 2 labs usually buy the lab because they have the volume, because volume equals revenue. So patents are important. AMFN is preparing for the future with revenues from the patents or exclusivity. In the lab business, they usually pay 5x the revenue. I know, it's less than the multiplier in other fields since it's 10 to 30 times more. What we have here—commercialization of Texatron, a fusion engine soon to power up data centers—is unique. Rarity also has a multiplier. Take a look, NFA. DYODD.😎 5737👀
0 · Reply
CapitalMonk
CapitalMonk Aug. 22 at 2:07 AM
$BDX Price: $192.00 (+2.33%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.59% RSI: 85.3 | Momentum: Moderate Volume: -7.2% vs avg Volatility: 1.72% Support: $157.09 | Resistance: $192.29 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 21 at 5:31 PM
$BDX printed a new 52-week high today
0 · Reply
ZacharyBrooks497
ZacharyBrooks497 Aug. 20 at 7:35 AM
$LHX $CBRS $DEO $BDX $STT L3Harris benefits from defense and aerospace spending, CBRS remains speculative, Diageo benefits from global beverage demand, Becton Dickinson benefits from medical-device and healthcare demand, and State Street benefits from asset servicing and investment activity. I'm watching defense contracts, liquidity, consumer volumes, procedure demand, and asset flows.
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 19 at 7:01 PM
$BDX printed a new 52-week high today
0 · Reply
heikoscreens
heikoscreens Aug. 18 at 5:55 PM
These are the current Dividend Aristocrats: $BDX $DOV $EMR $GWW $JNJ ...
1 · Reply
TalkMarkets
TalkMarkets Aug. 14 at 2:53 AM
Buy, Sell, Or Hold These 4 Dividend Kings After Earnings: BDX, ED, EMR, PH $BDX $ED $EMR $PH https://talkmarkets.com/article/buy-sell-or-hold-these-4-dividend-kings-after-earnings-bdx-ed-emr-ph-1786675988
0 · Reply
TalkMarkets
TalkMarkets Aug. 11 at 6:43 AM
BDX: A Dividend King In The Medical Supply Business $BDX Also Mentions: $WAT https://talkmarkets.com/article/bdx-a-dividend-king-in-the-medical-supply-business-1786430481
0 · Reply
AlphaTradingRoom
AlphaTradingRoom Aug. 6 at 4:41 PM
$BDX beat and raised. Medical devices are holding up better than people feared in this macro. But hospital budgets are the first thing CFOs cut when recession fears spike. Too early to call this a safe haven.
1 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 1:02 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-becton-dickinson-and-company-stock/ $BDX Becton, Dickinson and Company Earnings Trans
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 11:57 AM
$BDX Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.37 down -31.50% YoY • Reported revenue of $4.98B down -9.55% YoY • Becton, Dickinson and Company updates its full-year fiscal 2026 guidance, expecting revenue growth toward the high end of its range and raising the midpoint of its adjusted diluted EPS guidance range.
0 · Reply
knowinvest
knowinvest Aug. 6 at 11:34 AM
$BDX beat both top and bottom lines conformably, up 1.8% premarket
0 · Reply
LiveSquawk
LiveSquawk Aug. 6 at 10:32 AM
$BDX Becton Dickinson Q3 2026 Earnings - Adj EPS Cont OPS $3.23 (est $3.14) - Rev $5.0B (est $4.89B)
0 · Reply
chursinow62
chursinow62 Aug. 6 at 3:31 AM
$BDX going to shif the bed AM
0 · Reply
AngieJohnson768
AngieJohnson768 Aug. 5 at 6:45 AM
$EXC $ARES $VTR $BDX $FLEX Exelon provides dependable utility earnings, Ares Management grows alternative assets, Ventas benefits from healthcare real estate, Becton Dickinson leads medical devices, and Flex supports global electronics manufacturing.
0 · Reply
ZainCharts
ZainCharts Jul. 31 at 7:47 PM
THE SMALLEST NAME MOVED FASTEST 🟢 OTC: $NREDF +25.85% $NRED.CSE +22.22% $AMZN +15.31% 🔴 $AAPL -9.16% Scale did not decide the leaderboard. Momentum did. $BDX stayed near unchanged with August 6 on deck
0 · Reply
knowinvest
knowinvest Jul. 19 at 2:34 PM
$BDX money will rotate back to ihi and earning next month will be the catalyst for the sp to move back to old level
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 2 at 5:41 AM
$BDX Share Price: $152.90 Contract Selected: Dec 18, 2026 $155 Calls Buy Zone: $4.74 – $5.86 Target Zone: $8.34 – $10.19 Potential Upside: 66% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 23 at 5:40 PM
$BDX Share Price: $145.53 Contract Selected: Dec 18, 2026 $145 Calls Buy Zone: $38.67 – $47.77 Target Zone: $64.32 – $78.61 Potential Upside: 57% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 5:01 AM
$BDX Current Stock Price: $140.71 Contracts to trade: $140.0 BDX Jul 17 2026 Call Entry: $5.04 Exit: $7.69 ROI: 53% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
TalkMarkets
TalkMarkets Jun. 8 at 8:09 PM
10 #BenjaminGraham Stocks With High #Dividend Yields $AMCR $ANDE $BDX $BRO $FDS https://talkmarkets.com/article/10-benjamin-graham-stocks-with-high-dividend-yields-1780949291
0 · Reply